Literature DB >> 23583076

A cotranslational ubiquitination pathway for quality control of misfolded proteins.

Feng Wang1, Larissa A Durfee, Jon M Huibregtse.   

Abstract

Previous studies have indicated that 6%-30% of newly synthesized proteins are rapidly degraded by the ubiquitin-proteasome system; however, the relationship of ubiquitination to translation for these proteins has been unclear. We report that cotranslational ubiquitination (CTU) is a robust process, with 12%-15% of nascent polypeptides being ubiquitinated in human cells. CTU products contained primarily K48-linked polyubiquitin chains, consistent with a proteasomal targeting function. While nascent chains have been shown previously to be ubiquitinated within stalled complexes (CTU(S)), the majority of nascent chain ubiquitination occurred within active translation complexes (CTU(A)). CTU(A) was increased in response to agents that induce protein misfolding, while CTU(S) was increased in response to agents that lead to translational errors or stalling. These results indicate that ubiquitination of nascent polypeptides occurs in two contexts and define CTU(A) as a component of a quality control system that marks proteins for destruction while they are being synthesized.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583076      PMCID: PMC3654026          DOI: 10.1016/j.molcel.2013.03.009

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  49 in total

1.  Do more complex organisms have a greater proportion of membrane proteins in their genomes?

Authors:  T J Stevens; I T Arkin
Journal:  Proteins       Date:  2000-06-01

2.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes.

Authors:  U Schubert; L C Antón; J Gibbs; C C Norbury; J W Yewdell; J R Bennink
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

Review 3.  Macromolecular crowding: obvious but underappreciated.

Authors:  R J Ellis
Journal:  Trends Biochem Sci       Date:  2001-10       Impact factor: 13.807

4.  Detecting and measuring cotranslational protein degradation in vivo.

Authors:  G C Turner; A Varshavsky
Journal:  Science       Date:  2000-09-22       Impact factor: 47.728

5.  Quantitating protein synthesis, degradation, and endogenous antigen processing.

Authors:  Michael F Princiotta; Diana Finzi; Shu-Bing Qian; James Gibbs; Sebastian Schuchmann; Frank Buttgereit; Jack R Bennink; Jonathan W Yewdell
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

6.  The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit.

Authors:  D E Brodersen; W M Clemons; A P Carter; R J Morgan-Warren; B T Wimberly; V Ramakrishnan
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

7.  Aurintricarboxylic acid: inhibitor of initiation of protein synthesis.

Authors:  M L Stewart; A P Grollman; M T Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1971-01       Impact factor: 11.205

8.  Kinetics of degradation of "short-" and "long-lived" proteins in cultured mammalian cells.

Authors:  D N Wheatley; M R Giddings; M S Inglis
Journal:  Cell Biol Int Rep       Date:  1980-12

Review 9.  Inhibitors of ribosome functions.

Authors:  S Pestka
Journal:  Annu Rev Microbiol       Date:  1971       Impact factor: 15.500

10.  The major substrates for TAP in vivo are derived from newly synthesized proteins.

Authors:  E A Reits; J C Vos; M Grommé; J Neefjes
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

View more
  75 in total

1.  Nuclear translation for immunosurveillance.

Authors:  Jonathan W Yewdell; Alexandre David
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-18       Impact factor: 11.205

Review 2.  Perilous journey: a tour of the ubiquitin-proteasome system.

Authors:  Gary Kleiger; Thibault Mayor
Journal:  Trends Cell Biol       Date:  2014-01-20       Impact factor: 20.808

Review 3.  Re-examining class-I presentation and the DRiP hypothesis.

Authors:  Kenneth L Rock; Diego J Farfán-Arribas; Jeff D Colbert; Alfred L Goldberg
Journal:  Trends Immunol       Date:  2014-02-21       Impact factor: 16.687

4.  O-GlcNAc occurs cotranslationally to stabilize nascent polypeptide chains.

Authors:  Yanping Zhu; Ta-Wei Liu; Samy Cecioni; Razieh Eskandari; Wesley F Zandberg; David J Vocadlo
Journal:  Nat Chem Biol       Date:  2015-03-16       Impact factor: 15.040

5.  Translation: An O-GlcNAc stamp of approval.

Authors:  Evan T Powers
Journal:  Nat Chem Biol       Date:  2015-03-16       Impact factor: 15.040

6.  MISTERMINATE Mechanistically Links Mitochondrial Dysfunction with Proteostasis Failure.

Authors:  Zhihao Wu; Ishaq Tantray; Junghyun Lim; Songjie Chen; Yu Li; Zoe Davis; Cole Sitron; Jason Dong; Suzana Gispert; Georg Auburger; Onn Brandman; Xiaolin Bi; Michael Snyder; Bingwei Lu
Journal:  Mol Cell       Date:  2019-08-01       Impact factor: 17.970

7.  Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD.

Authors:  Shuangxi Li; Zhihao Wu; Ishaq Tantray; Yu Li; Songjie Chen; Jason Dong; Steven Glynn; Hannes Vogel; Michael Snyder; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

Review 8.  Proteome complexity and the forces that drive proteome imbalance.

Authors:  J Wade Harper; Eric J Bennett
Journal:  Nature       Date:  2016-09-15       Impact factor: 49.962

Review 9.  Ribosome-based quality control of mRNA and nascent peptides.

Authors:  Carrie L Simms; Erica N Thomas; Hani S Zaher
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-05-18       Impact factor: 9.957

10.  A Two-step Protein Quality Control Pathway for a Misfolded DJ-1 Variant in Fission Yeast.

Authors:  Søs G Mathiassen; Ida B Larsen; Esben G Poulsen; Christian T Madsen; Elena Papaleo; Kresten Lindorff-Larsen; Birthe B Kragelund; Michael L Nielsen; Franziska Kriegenburg; Rasmus Hartmann-Petersen
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.